Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-06-05 Purchase |
2025-06-09 06:03 am |
RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer |
21,000 | $1.4 | $29,400 | 734,460 (Direct) |
View |
| 2025-04-15 Purchase |
2025-04-17 06:10 am |
RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer |
15,000 | $0.9 | $13,500 | 1,113,460 (Direct) |
View |
| 2025-04-15 Purchase |
2025-04-16 06:08 am |
RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer |
7,500 | $0.9095 | $6,821 | 320,040 (Direct) |
View |
| 2025-04-11 Purchase |
2025-04-14 06:30 am |
RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer |
20,000 | $0.8 | $16,000 | 1,098,460 (Direct) |
View |
| 2025-04-08 Purchase |
2025-04-10 7:02 pm |
RenovoRx Inc. | RNXT | Kocak Ron VP Controller and PAO |
12,595 | $0.79484 | $10,011 | 12,595 (Direct) |
View |
| 2025-04-09 Purchase |
2025-04-10 4:30 pm |
RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer |
30,000 | $0.8133 | $24,399 | 1,078,460 (Direct) |
View |
| 2025-04-09 Purchase |
2025-04-10 06:02 am |
RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer |
10,000 | $0.83 | $8,300 | 312,540 (Direct) |
View |
| 2025-04-08 Purchase |
2025-04-09 9:30 pm |
RenovoRx Inc. | RNXT | Marton Laurence Director |
12,050 | $0.848 | $10,218 | 45,684 (Direct) |
View |
| 2025-04-08 Purchase |
2025-04-09 12:45 pm |
RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer |
26,000 | $0.84 | $21,840 | 1,048,460 (Direct) |
View |
| 2025-04-07 Purchase |
2025-04-08 11:30 am |
RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer |
10,000 | $0.83 | $8,300 | 302,540 (Direct) |
View |
| 2024-01-26 Purchase |
2024-01-30 7:33 pm |
RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer |
40,983 | $0 | $0 | 88,443 (Direct) |
View |
| 2024-01-26 Purchase |
2024-01-30 7:00 pm |
RenovoRx Inc. | RNXT | Spiegel Robert J. Director |
40,983 | $0 | $0 | 81,966 (Direct) |
View |
| 2024-01-26 Purchase |
2024-01-30 6:57 pm |
RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer |
40,983 | $0 | $0 | 333,523 (Direct) |
View |
| 2024-01-26 Purchase |
2024-01-30 6:32 pm |
RenovoRx Inc. | RNXT | Marton Laurence Director |
8,196 | $0 | $0 | 41,830 (Direct) |
View |
| 2024-01-26 Purchase |
2024-01-30 6:30 pm |
RenovoRx Inc. | RNXT | Macfarlane K. Angela Director |
40,983 | $0 | $0 | 81,966 (Direct) |
View |
| 2023-10-03 Purchase |
2023-10-04 4:44 pm |
RenovoRx Inc. | RNXT | Nelms Angela Chief Operating Officer |
1,100 | $1.0463 | $1,151 | 1,100 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-07-01 Option Award |
2025-07-03 4:45 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer |
63,636 | $0 | 63,636 (Direct) |
View |
| 2025-07-01 Option Award |
2025-07-03 4:45 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer |
102,498 | $0 | 102,498 (Direct) |
View |
| 2025-07-01 Option Award |
2025-07-03 4:45 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer |
6,619 | $0 | 6,619 (Direct) |
View |
| 2025-07-01 Option Award |
2025-07-03 4:45 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Kocak Ron VP, Controller and PAO |
41,600 | $0 | 41,600 (Direct) |
View |
| 2025-04-22 Gift |
2025-06-06 5:15 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer |
400,000 | $0 | 713,460 (Direct) |
View |
| 2025-05-02 Exercise |
2025-05-06 4:10 pm |
N/A 2025-10-14 |
RenovoRx Inc. | RNXT | Marton Laurence Director |
20,480 | $0 | 66,164 (Direct) |
View |
| 2025-05-02 Exercise |
2025-05-06 4:10 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Marton Laurence Director |
20,480 | $0.15 | 66,164 (Direct) |
View |
| 2025-04-14 Option Award |
2025-04-16 5:18 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer |
409,992 | $0 | 409,992 (Direct) |
View |
| 2025-04-14 Option Award |
2025-04-16 5:18 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer |
26,477 | $0 | 26,477 (Direct) |
View |
| 2025-04-14 Option Award |
2025-04-16 5:18 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Kocak Ron VP, Controller and PAO |
166,400 | $0 | 166,400 (Direct) |
View |
| 2025-04-14 Option Award |
2025-04-16 5:18 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer |
254,542 | $0 | 254,542 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-02 4:30 pm |
N/A 2034-10-01 |
RenovoRx Inc. | RNXT | RYAN UNA S Director |
25,099 | $0 | 25,099 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-02 4:30 pm |
N/A 2034-10-01 |
RenovoRx Inc. | RNXT | Macfarlane K. Angela Director |
25,099 | $0 | 25,099 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-02 4:30 pm |
N/A 2034-10-01 |
RenovoRx Inc. | RNXT | Marton Laurence Director |
25,099 | $0 | 25,099 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-02 4:30 pm |
N/A 2034-10-01 |
RenovoRx Inc. | RNXT | Spiegel Robert J. Director |
25,099 | $0 | 25,099 (Direct) |
View |
| 2024-03-06 Option Award |
2024-03-08 4:28 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer |
190,000 | $0 | 190,000 (Direct) |
View |
Ownership |
2024-03-08 4:26 pm |
2023-06-01 N/A |
RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer |
0 | $0 | 142,072 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-12 7:46 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Kocak Ron VP, Controller and PAO |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2024-02-12 7:39 pm |
2022-08-18 N/A |
RenovoRx Inc. | RNXT | Kocak Ron VP, Controller and PAO |
0 | $0 | 113,641 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-23 9:50 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Nelms Angela Chief Operating Officer |
158,900 | $0 | 158,900 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-23 9:50 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer |
153,556 | $0 | 153,556 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-23 9:50 pm |
N/A N/A |
RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer |
317,236 | $0 | 317,236 (Direct) |
View |
| 2023-10-01 Option Award |
2023-10-02 4:15 pm |
N/A 2033-10-01 |
RenovoRx Inc. | RNXT | Spiegel Robert J. Director |
25,099 | $0 | 25,099 (Direct) |
View |
| 2023-10-01 Option Award |
2023-10-02 4:15 pm |
N/A 2033-10-01 |
RenovoRx Inc. | RNXT | Marton Laurence Director |
25,099 | $0 | 25,099 (Direct) |
View |
| 2023-10-01 Option Award |
2023-10-02 4:15 pm |
N/A 2033-10-01 |
RenovoRx Inc. | RNXT | RYAN UNA S Director |
25,099 | $0 | 25,099 (Direct) |
View |